Telavancin hydrochlorideProduct ingredient for Telavancin
- Name
- Telavancin hydrochloride
- Drug Entry
- Telavancin
Telavancin is a semi-synthetic derivative of vanocymycin that has bactericidal activity against Methicillin-resistant Staphylococcus aureus (MRSA) and other gram-positive bacteria. MRSA is an important pathogen capable of causing hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP), and skin and subcutaneous tissue infections among others.
- Accession Number
- DBSALT000170
- Structure
Structure for Telavancin hydrochloride (DBSALT000170)
- Synonyms
- Telavancin HCl
- External IDs
- TD 6424 / TD-6424
- UNII
- 0701472ZG0
- CAS Number
- 560130-42-9
- Weight
- Average: 1792.096
Monoisotopic: 1789.614106906 - Chemical Formula
- C80H107Cl3N11O27P
- InChI Key
- GSSIWSIRBWAZHG-ACOPVEIWSA-N
- InChI
- InChI=1S/C80H106Cl2N11O27P.ClH/c1-7-8-9-10-11-12-13-14-21-85-22-23-87-80(5)32-57(115-37(4)71(80)103)119-70-68(102)67(101)55(34-94)118-79(70)120-69-53-28-41-29-54(69)117-52-20-17-40(27-46(52)82)65(99)63-77(109)91-61(78(110)111)43-30-50(96)44(33-86-35-121(112,113)114)66(100)58(43)42-25-38(15-18-49(42)95)59(74(106)93-63)90-75(107)60(41)89-73(105)48(31-56(83)97)88-76(108)62(92-72(104)47(84-6)24-36(2)3)64(98)39-16-19-51(116-53)45(81)26-39;/h15-20,25-30,36-37,47-48,55,57,59-65,67-68,70-71,79,84-87,94-96,98-103H,7-14,21-24,31-35H2,1-6H3,(H2,83,97)(H,88,108)(H,89,105)(H,90,107)(H,91,109)(H,92,104)(H,93,106)(H,110,111)(H2,112,113,114);1H/t37-,47+,48-,55+,57-,59+,60+,61-,62+,63-,64+,65+,67+,68-,70+,71+,79-,80-;/m0./s1
- IUPAC Name
- (1S,2R,18R,19R,22S,25R,28R,40S)-22-(carbamoylmethyl)-47,49-dichloro-48-{[(2S,3R,4S,5S,6R)-3-{[(2S,4S,5S,6S)-4-{[2-(decylamino)ethyl]amino}-5-hydroxy-4,6-dimethyloxan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,18,32,35,37-pentahydroxy-19-[(2R)-4-methyl-2-(methylamino)pentanamido]-20,23,26,42,44-pentaoxo-36-{[(phosphonomethyl)amino]methyl}-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2^{3,6}.2^{14,17}.1^{8,12}.1^{29,33}.0^{10,25}.0^{34,39}]pentaconta-3,5,8,10,12(48),14,16,29,31,33(45),34(39),35,37,46,49-pentadecaene-40-carboxylic acid hydrochloride
- SMILES
- Cl.CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2OC2=C3OC4=CC=C(C=C4Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]4C(C=C2OC2=CC=C(C=C2Cl)[C@@H](O)[C@@H]2NC(=O)[C@H](NC4=O)C4=CC=C(O)C(=C4)C4=C(C=C(O)C(CNCP(O)(O)=O)=C4O)[C@H](NC2=O)C(O)=O)=C3)O[C@@H](C)[C@H]1O
- External Links
- KEGG Drug
- D06057
- PubChem Compound
- 49800074
- ChemSpider
- 7988466
- ChEBI
- 71226
- ChEMBL
- CHEMBL3301680
- Wikipedia
- Telavancin
- Predicted Properties
Property Value Source Water Solubility 0.0148 mg/mL ALOGPS logP 2.32 ALOGPS logP -6.2 Chemaxon logS -5.1 ALOGPS pKa (Strongest Acidic) 1.55 Chemaxon pKa (Strongest Basic) 9.99 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 29 Chemaxon Hydrogen Donor Count 23 Chemaxon Polar Surface Area 598.09 Å2 Chemaxon Rotatable Bond Count 30 Chemaxon Refractivity 429.41 m3·mol-1 Chemaxon Polarizability 175.13 Å3 Chemaxon Number of Rings 10 Chemaxon Bioavailability 0 Chemaxon Rule of Five No Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule Yes Chemaxon